Forty People Sue Over Dupixent
Forty people have filed lawsuits about Dupixent, which patients use for eczema but which has been linked to cutaneous T-cell lymphoma. The first person to file suit was a woman who lost her mother in 2024; her mom had developed medical problems soon after her first injection, according to the plaintiff. If you or a loved one developed T-cell lymphoma after using Dupixent, you should call the seasoned Chicago-based product liability lawyers of Moll Law Group to see whether you have a viable claim. Billions have been recovered in cases with which we’ve been involved.
Consult Moll Law Group About Your Claim
The litigation over Dupixent has built. There are now 40 federal cases that have been consolidated. More than 12 cases have been brought in state court. The plaintiff’s attorney has explained that sometimes T-cell lymphoma and eczema are confused by doctors. When a patient comes in, the doctor may diagnose eczema when the actual cause of the symptoms is T-cell lymphoma and prescribe Dupixent. Unfortunately, Dupixent can accelerate the progression of T-cell lymphoma.
The plaintiff’s attorney wants drug manufacturers to warn doctors to ensure that the patients don’t have T-cell lymphoma, which may be dormant prior to the taking of Dupixent.
The manufacturer Sanofi has emphasized the benefits outweigh the risks of Dupixent when used appropriately. It has announced that it doesn’t believe the scientific literature supports a causal connection between Dupixent and cutaneous T-cell lymphoma. It explained that a regulatory authority concluded the same thing.
If you were injured by Dupixent, you may wish to bring a product liability lawsuit. These lawsuits can be pursued in connection with design, manufacturing, or marketing defects. A common marketing defect is failure to warn.
The first thing we would need to prove in a failure to warn case is that the manufacturer or seller owed a legal duty to warn about risks arising out of use of the product at issue. Federal law mandates that every consumer has the right to know of any known or foreseeable dangers associated with a product’s use. Makers and sellers are expected to communicate the risk to consumers.
Additionally, we would need to prove that the danger of harm associated with Dupixent was reasonably foreseeable to the seller or manufacturer once the product became available. In other words, they must have had actual knowledge or should have known about the risk via testing, industry standards or research.
We must also show causation or a direct link between the failure to provide an adequate warning and the injuries suffered. The question is whether providing an acceptable warning would have known about the risks and would have taken the right steps to stay safe. However, the learned intermediary doctrine provides that the manufacturer fulfills the duty to warn consumers by giving adequate warnings to the prescribing health care provider rather than the patient.
Discuss Your Injuries With a Product Liability Attorney
If you were harmed by Dupixent, please call the experienced Chicago-based product liability lawyers of Moll Law Group to find out whether you have a basis to bring a lawsuit. Complete our online form or call us at 312.462.1700.
Illinois Injury and Mass Tort Lawyer Blog

